Goranov B - Search Results

1

Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review.

Shahid Iqbal M, Kelly C, Kovarik J, Goranov B, Shaikh G, Morgan D, Dobrowsky W, Paleri V. Shahid Iqbal M, et al. Among authors: goranov b. Radiother Oncol. 2018 Mar;126(3):558-567. doi: 10.1016/j.radonc.2017.12.011. Epub 2018 Jan 19. Radiother Oncol. 2018. PMID: 29370986 Review.

2

Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A survey of UK national practice.

Iqbal MS, Kelly C, Kovarik J, Goranov B, Shaikh G, Morgan D, Dobrowsky W, Paleri V. Iqbal MS, et al. Among authors: goranov b. Radiother Oncol. 2018 Mar;126(3):568-569. doi: 10.1016/j.radonc.2017.11.017. Epub 2018 Jan 30. Radiother Oncol. 2018. PMID: 29366519 No abstract available.

3

In Response to Adizie et al. Stage III Non-small Cell Lung Cancer Management in England.

Young T, Pollock C, Daneshvar C, Sevitt T, Goranov B. Young T, et al. Among authors: goranov b. Clin Oncol (R Coll Radiol). 2020 Oct;32(10):e209. doi: 10.1016/j.clon.2020.05.014. Epub 2020 Jun 12. Clin Oncol (R Coll Radiol). 2020. PMID: 32536558 No abstract available.

4

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr; KEYNOTE-177 Investigators. André T, et al. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Free article. Clinical Trial.

5

Academic opportunities within clinical oncology training.

Goranov BB, Drew Y, Graham J, Iqbal MS, Kagzi M, Mahtab N, Pearson R, Smith E, Mulvenna P. Goranov BB, et al. Clin Oncol (R Coll Radiol). 2013 Jul;25(7):446. doi: 10.1016/j.clon.2013.03.004. Epub 2013 Apr 11. Clin Oncol (R Coll Radiol). 2013. PMID: 23582955 No abstract available.

6

Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression.

Carr-Wilkinson J, Griffiths R, Elston R, Gamble LD, Goranov B, Redfern CP, Lunec J, Tweddle DA. Carr-Wilkinson J, et al. Among authors: goranov b. Cell Cycle. 2011 Nov 1;10(21):3778-87. doi: 10.4161/cc.10.21.17973. Epub 2011 Nov 1. Cell Cycle. 2011. PMID: 22052359

7

Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types.

Gentles L, Goranov B, Matheson E, Herriott A, Kaufmann A, Hall S, Mukhopadhyay A, Drew Y, Curtin NJ, O'Donnell RL. Gentles L, et al. Among authors: goranov b. Cancers (Basel). 2019 Mar 13;11(3):354. doi: 10.3390/cancers11030354. Cancers (Basel). 2019. PMID: 30871186 Free PMC article.

8

Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells.

Lovat PE, Oliverio S, Corazzari M, Rodolfo C, Ranalli M, Goranov B, Melino G, Redfern CP, Piacentini M. Lovat PE, et al. Among authors: goranov b. Cancer Res. 2003 Nov 1;63(21):7310-3. Cancer Res. 2003. PMID: 14612528

9

Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells.

Lovat PE, Corazzari M, Goranov B, Piacentini M, Redfern CP. Lovat PE, et al. Among authors: goranov b. Ann N Y Acad Sci. 2004 Dec;1028:81-9. doi: 10.1196/annals.1322.009. Ann N Y Acad Sci. 2004. PMID: 15650234 Review.

10

Cytogenetic differences and neuroblastoma cell interconversion.

Goranov BB, Redfern CP. Goranov BB, et al. Cancer Genet Cytogenet. 2004 Mar;149(2):173-4; author reply 175. doi: 10.1016/S0165-4608(03)00311-X. Cancer Genet Cytogenet. 2004. PMID: 15036895 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters